Reckitt's Lysol Innovation Leads Launches As Acquisition Talk Subsides
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser looks to continue feeding organic growth through innovative product launches, as discussion of the company's acquisition search has quieted in recent months
You may also be interested in...
Perrigo Benefits From McNeil Recall, Prepares Infant Formula Launches
Johnson & Johnson's extensive recall of leading brand name analgesics spurred sales growth for Perrigo's private-label products in the category during the firm's most recent earnings period
FDA Denial Of Mucinex Petition Stops Reckitt's Bid To Delay Generics
FDA stymies Reckitt Benckiser's attempt to delay private label competition for Mucinex OTC cough products by rejecting the firm's request to redefine bioequivalence standards for guaifenesin generics
Reckitt Benckiser Tops Acquisition Speculation In Personal Care
As consumer products merger and acquisition activity revives, analysts are speculating which players in the personal care arena may be winding up for deals, with U.K.-based Reckitt Benckiser named a likely suspect